Combined DES/SD model of breast cancer screening for older women, II: screening-and-treatment simulation

被引:16
|
作者
Tejada, Jeremy J. [1 ]
Ivy, Julie S. [2 ]
King, Russell E. [2 ]
Wilson, James R. [2 ]
Ballan, Matthew J. [2 ]
Kay, Michael G. [2 ]
Diehl, Kathleen M. [3 ]
Yankaskas, Bonnie C. [4 ,5 ]
机构
[1] SIMCON Solut LLC, Dallas, TX 75235 USA
[2] N Carolina State Univ, Edward P Fitts Dept Ind & Syst Engn, Raleigh, NC 27695 USA
[3] Univ Michigan Hlth Syst, Div Surg Oncol, Dept Surg, Ann Arbor, MI 48109 USA
[4] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27516 USA
[5] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27516 USA
关键词
discrete-event simulation; breast cancer; medical decision making; screening older U.S. women; Health care; system dynamics; combined discrete-continuous simulation;
D O I
10.1080/0740817X.2013.851436
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
In the second article of a two-article sequence, the focus is on a simulation model for screening and treatment of breast cancer in U.S. women of age 65+. The first article details a natural-history simulation model of the incidence and progression of untreated breast cancer in a representative simulated population of older U.S. women, which ultimately generates a database of untreated breast cancer histories for individuals in the simulated population. Driven by the resulting database, the screening-and-treatment simulation model is composed of discrete-event simulation (DES) and system dynamics (SD) submodels. For each individual in the simulated population, the DES submodel simulates screening policies and treatment procedures to estimate the resulting survival rates and the costs of screening and treatment. The SD submodel represents the overall structure and operation of the U.S. system for detecting and treating breast cancer. The main results and conclusions are summarized, including a final recommendation for annual screening between ages 65 and 80. A discussion is also presented on how both the natural-history and screening-and-treatment simulations can be used for performance comparisons of proposed screening policies based on overall cost-effectiveness, the numbers of life-years and quality-adjusted life-years saved, and the main components of the total cost incurred by each policy.
引用
收藏
页码:707 / 727
页数:21
相关论文
共 50 条